We further analyzed the mRNA expression level of PIP4K2A in patient-derived GBM cells compared with the neural progenitor cells (NPCs) and found that PIP4K2A expression was significantly higher in NPCs compared to the GBMs as well (Fig. 1 I). This evidence concerns the gene PIP4K2A and glioblastoma.